Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Meridian Street Capital is a New York-based venture capital firm founded in 2016, focusing exclusively on early-stage healthcare technology companies. The firm emphasizes the integration of technology within the healthcare sector, supporting founders from the inception of their ideas. Meridian Street Capital adopts a concentrated portfolio approach, allowing them to provide steadfast partnership and focused support to a select group of companies.
As of now, Meridian Street Capital manages a portfolio of 37 companies, showcasing their commitment to the healthcare technology space. The firm primarily invests at the pre-seed, seed, and seed-plus stages, often joining founders at the very beginning of their entrepreneurial journeys. Their notable exits include companies like Decent, First Dollar, and Hint Health, demonstrating a strong track record in the industry.
Meridian Street Capital invests primarily in early-stage healthcare companies that leverage technology to enhance healthcare delivery. Their investment strategy is centered around the intersection of healthcare and technology, focusing on innovations that improve patient health, access, costs, and experience. The firm typically engages with startups at the pre-seed, seed, and seed-plus stages, providing support and resources to help bring innovative solutions to market.
Meridian Street Capital looks for founders who are passionate about transforming healthcare through technology. They prefer to take board seats or observer roles, allowing them to be actively involved in strategic decision-making. This hands-on approach enables them to build strong partnerships with their portfolio companies, ensuring that they can navigate the complexities of the healthcare technology landscape effectively.
Meridian Street Capital's portfolio includes a diverse range of companies that are making significant strides in healthcare technology. Notable companies in their active portfolio include:
In addition to their active portfolio, Meridian Street Capital has achieved notable exits with companies such as Decent, First Dollar, Hint Health, Included Health, Tenure Health, and Valify, showcasing their ability to identify and support successful healthcare technology ventures.
Scott Law - Partner: Scott co-leads investment decisions at Meridian Street Capital. He has extensive experience in venture capital and has been involved in numerous successful healthcare technology investments.
George Ribaroff, MD - Partner: George also co-leads investment decisions and brings a medical background to the firm, enhancing their understanding of healthcare needs and opportunities.
Brianna Yarnoff - Investor: Brianna focuses on sourcing and evaluating new investment opportunities within the healthcare technology sector.
Robel Mulugeta - Investor: Robel is involved in due diligence and supports portfolio companies in their growth strategies.
Matt Shiflett - Director of Finance: Matt oversees financial operations and fund management, ensuring the firm’s financial health.
Caroline Targgart - Executive Assistant: Caroline provides administrative support to the team, facilitating smooth operations.
Jimmy Comfort - Venture Partner: Jimmy contributes to investment strategy and portfolio management, leveraging his extensive network in the healthcare sector.
To pitch Meridian Street Capital, founders should reach out via email at info@meridianstreetcapital.com. It is important to include a comprehensive pitch deck that outlines the business model, market opportunity, and team background. Founders should expect a response within a few weeks, although timelines may vary based on deal flow and internal processes. Warm introductions are preferred but not mandatory.
In 2026, Meridian Street Capital added several new companies to their portfolio, including Loula, a digital health solution for women's health, and Prava Therapy, a platform for therapy services. In 2025, they invested in Onboard AI, an AI-driven platform for healthcare insights, and Quilt Health, a personalized healthcare platform. In 2024, they welcomed Qualtech, a healthcare technology firm specializing in quality improvement.
The firm has maintained a consistent deal flow since its inception in 2016, achieving six notable exits, including Decent, First Dollar, and Hint Health. This strong exit rate reflects their ability to identify and support successful healthcare technology ventures.
What are Meridian Street Capital's investment criteria?
Meridian Street Capital focuses on early-stage healthcare technology companies, particularly those that leverage technology to enhance healthcare delivery. They typically invest at the pre-seed, seed, and seed-plus stages.
How can I apply or pitch to Meridian Street Capital?
Founders can pitch their ideas by reaching out via email at info@meridianstreetcapital.com. It is advisable to include a detailed overview of the business model, market opportunity, and team background in the pitch.
What makes Meridian Street Capital different from other venture capital firms?
Meridian Street Capital emphasizes a concentrated portfolio approach, allowing them to provide focused support and collaboration with a select group of companies. Their active involvement in strategic decision-making sets them apart.
What is the geographic scope of Meridian Street Capital's investments?
The firm is based in New York and primarily invests in healthcare technology companies within the United States, although they may consider international opportunities that align with their investment thesis.
What is Meridian Street Capital's post-investment involvement like?
Meridian Street Capital takes an active role in their portfolio companies, often taking board seats or observer roles. They provide guidance and resources to help navigate the complexities of the healthcare technology landscape.
What is the typical check size for investments made by Meridian Street Capital?
While specific check sizes are not disclosed, the firm typically invests at the seed and Series A stages, which generally range from hundreds of thousands to a few million dollars.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.